SPRUCE BIOSCIENCES, INC. cotiza a 40.35 USD y tiene una capitalización bursátil de $116M. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Spruce Biosciences, Inc. is a biopharmaceutical company focused on developing and commercializing novel therapies for neurological disorders. The company develops TA-ERT, a fusion protein comprised of recombinant human alpha-N-acetylglucosaminidase, which is an enzyme replacement therapy for patients with Sanfilippo Sy…
| Periodo | 2026-08 | 2026-05 | 2026-03 | 2025-11 |
|---|---|---|---|---|
| Real | $-6.68 | $-8.94 | $-9.58 | $-14.58 |
| Estimado | $-5.93 | $-6.11 | $-9.56 | $-12.31 |
| Sorpresa | -12.6% | -46.3% | -0.2% | -18.4% |
| Métrica | SPRB | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | — | 57.0% | — |
| Operating Margin | — | -38.6% | — |
| Net Margin | — | -33.6% | — |
| FCF Margin | — | -13.9% | — |
| ROE | -91.7% | -40.4% | -51.3% |
| ROA | -73.5% | -32.0% | -41.5% |
| Current Ratio | 5.17 | 2.84 | +2.33 |
| Debt / Equity | 0.00 | 0.28 | -0.28 |